Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Euronext Paris 08/07/2025			5-day change	1st Jan Change
2.400 ^EUR	-.--%		-.--%	-96.67%

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 147K 121K 109K 205K 14.12M 206K 1.44M 556K 7.16M 553K 540K 22.82M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.28M 12.51M 11.36M 21.29M 1.47B 21.42M 149M 57.72M 743M 57.39M 56.12M 2.37B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
27/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
05/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe Orthopaedics SA Stock Euronext Paris

Stocks

ALSAF

FR001400RKU0

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics SA

Latest news: Safe Orthopaedics SA

Press Releases: Safe Orthopaedics SA

News in other languages: Safe Orthopaedics SA

Managers and Directors: Safe Orthopaedics SA

Medical Devices & Implants

Financials

Company Profile

09-08	SAFE : point sur l'audience du 7 septembre 2026 devant le Tribunal des activités économiques de Lyon
08-25	SAFE Group : point sur la suspension de cotation et sur la certification des comptes annuels 2025
06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS SA	-.--%	-.--%	-	-	147K
STRYKER CORPORATION	+1.16%	+3.40%	-24.39%	-2.74%	109B
SMITH & NEPHEW PLC	+0.43%	+1.61%	-24.36%	-2.11%	11.79B
GLAUKOS CORPORATION	-4.78%	-9.08%	+98.51%	+117.61%	9.64B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.57%	-2.19%	-53.85%	-71.49%	3.99B
DOUBLE MEDICAL TECHNOLOGY INC.	-1.25%	-3.88%	-29.61%	+21.67%	2.33B
INSPIRE MEDICAL SYSTEMS, INC.	-2.48%	+9.43%	-9.96%	-65.51%	2.1B
INSIGHT LIFETECH CO., LTD.	0.00%	-2.98%	-	-	1.82B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.19%	-1.78%	-22.36%	-30.15%	1.52B
Average	-0.57%	+0.27%	-9.43%	-4.67%	17.8B
Weighted average by Cap.	+0.57%	+2.22%	-16.65%	+2.78%

	2024	2025
Net sales	5.04M 5.82M 4.76M 4.33M 8.11M 558M 8.16M 56.88M 21.98M 283M 21.85M 21.37M 902M	5.36M 6.19M 5.07M 4.6M 8.63M 594M 8.68M 60.52M 23.39M 301M 23.25M 22.74M 960M
Net income	-1.93B -2.23B -1.82B -1.66B -3.1B -214B -3.12B -21.77B -8.41B -108B -8.36B -8.18B -345B	-4.67M -5.39M -4.42M -4.01M -7.52M -517M -7.56M -52.74M -20.38M -262M -20.26M -19.81M -836M
Net Debt	11.47M 13.24M 10.84M 9.84M 18.45M 1.27B 18.56M 129M 50.01M 644M 49.72M 48.62M 2.05B	13.11M 15.13M 12.39M 11.25M 21.09M 1.45B 21.21M 148M 57.17M 736M 56.84M 55.58M 2.35B